Home > National Drug Code (NDC) > Lithium Carbonate

Lithium Carbonate - 0615-1311-39 - (Lithium Carbonate)

Alphabetical Index


Drug Information of Lithium Carbonate

Product NDC: 0615-1311
Proprietary Name: Lithium Carbonate
Non Proprietary Name: Lithium Carbonate
Active Ingredient(s): 300    mg/1 & nbsp;   Lithium Carbonate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Lithium Carbonate

Product NDC: 0615-1311
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017812
Marketing Category: NDA
Start Marketing Date: 19801126

Package Information of Lithium Carbonate

Package NDC: 0615-1311-39
Package Description: 30 CAPSULE, GELATIN COATED in 1 BLISTER PACK (0615-1311-39)

NDC Information of Lithium Carbonate

NDC Code 0615-1311-39
Proprietary Name Lithium Carbonate
Package Description 30 CAPSULE, GELATIN COATED in 1 BLISTER PACK (0615-1311-39)
Product NDC 0615-1311
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lithium Carbonate
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 19801126
Marketing Category Name NDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name LITHIUM CARBONATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Mood Stabilizer [EPC]

Complete Information of Lithium Carbonate


General Information